Inventor · disambiguated record
Thomas Arrhenius
Also filed as: ARRHENIUS THOMAS · ARRHENIUS THOMAS S
24 granted patents·3 pending applications·457 citations·filing 1995–2010
95Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD12CYTEL CORP9ARRHENIUS THOMAS2CHENG JIE FEI1SCRIPPS RESEARCH INST1
Top patents by PatentIndex Score
27 records- 0194US5770573ACS-1 peptidomimetics, compositions and methods of using the sameCYTEL CORP·Filed 1995·Granted Jun 23, 1998·168 cites·14 claims
- 0287US5679640AImmunosuppressant peptidesCYTEL CORP·Filed 1995·Granted Oct 21, 1997·89 cites·17 claims
- 0386US7449482B2Piperidine compounds useful as malonyl-CoA decarboxylase inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Nov 11, 2008·25 cites·5 claims
- 0479US5821231ACS-1 peptidomimetics, compositions and methods of using sameCYTEL CORP·Filed 1995·Granted Oct 13, 1998·50 cites·25 claims
- 0575US5936065ACS-1 peptidomimetics, compositions and methods of using the sameCYTEL CORP·Filed 1995·Granted Aug 10, 1999·41 cites·2 claims
- 0675US5688913ACS-1 peptidomimetics, compositions and methods of using the sameCYTEL CORP·Filed 1995·Granted Nov 18, 1997·25 cites·18 claims
- 0774US7026491B2Coumarin derivatives useful as TNFα inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Granted Apr 11, 2006·6 cites·3 claims
- 0869US7385063B2Method for preparing imidazole derivativesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Jun 10, 2008·5 cites·12 claims
- 0966US7524969B2Malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Apr 28, 2009·3 cites·5 claims
- 1059US5869448ACyclic CS-1 peptidomimetics, compositions and methods of using sameCYTEL CORP·Filed 1995·Granted Feb 9, 1999·20 cites·23 claims
- 1158US7709664B2Coumarin derivatives useful as TNFα inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted May 4, 2010·0 cites·2 claims
- 1256US5811391ACyclic CS-1 peptidomimetics, compositions and methods of using sameCYTEL CORP·Filed 1995·Granted Sep 22, 1998·9 cites·27 claims
- 1355US8119819B2Malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsARRHENIUS THOMAS·Filed 2009·Granted Feb 21, 2012·0 cites·4 claims
- 1455US8080665B2Piperidine compounds useful as malonyl-CoA decarboxylase inhibitorsCHENG JIE FEI·Filed 2008·Granted Dec 20, 2011·0 cites·3 claims
- 1554US2008070869A1Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic ModulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2007·Application pending·0 cites
- 1653US7994318B2Coumarin derivatives useful as TNFα inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Granted Aug 9, 2011·0 cites·3 claims
- 1753US7872142B2Coumarin derivatives useful as TNFα inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Granted Jan 18, 2011·0 cites·2 claims
- 1852US7786145B2Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Aug 31, 2010·0 cites·3 claims
- 1950US7709510B2Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted May 4, 2010·0 cites·8 claims
- 2050US6117840ACS-1 peptidomimetics, compositions and methods of using the sameCYTEL CORP·Filed 1997·Granted Sep 12, 2000·9 cites·36 claims
- 2147US7279477B2Malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Oct 9, 2007·0 cites·14 claims
- 2240US8110686B2Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsARRHENIUS THOMAS·Filed 2010·Granted Feb 7, 2012·0 cites·4 claims
- 2340US7723366B2Azole compounds as malonyl-CoA decarboxylase inhibitors for treating metabolic diseasesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted May 25, 2010·0 cites·2 claims
- 2438US5807979ASynthetic, three-dimensionally stabilized polypeptide mimics of HIVSCRIPPS RESEARCH INST·Filed 1995·Granted Sep 15, 1998·7 cites·5 claims
- 2537US2006025474A1Bisphenyl compounds useful as vitamin D3 receptor agonistsWALLACE DAVID·Filed 2005·Application pending·0 cites
- 2637US2004110757A1Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesisFiled 2002·Application pending·0 cites
- 2732US6103870ACS-1 peptidomimetic, compositions and methods of using the sameCYTEL CORP·Filed 1997·Granted Aug 15, 2000·0 cites·28 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →